INTERNATIONAL PATENT: SCRIBE THERAPEUTICS INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR THE TARGETING OF APOLIPOPROTEIN C3"

GENEVA, Nov. 26 -- SCRIBE THERAPEUTICS INC. (1150 Marina Village ParkwayAlameda, California 94501) filed a patent application (PCT/US2025/029877) for "COMPOSITIONS AND METHODS FOR THE TARGETING OF APOLIPOPROTEIN C3" on May 16, 2025. With publication no. WO/2025/240940, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BUCHER, Simon Pierre Jean (c/o Scribe Therapeutics Inc.1150 Marina Village ParkwayAlameda, California 94501), KARANTH, Santhosh (c/o Scribe Therapeutics Inc.1150 Marina Village ParkwayAlameda, California 94501...